首页> 外文期刊>The Journal of biological chemistry >Porphyromonas gingivalis Virulence Factor Gingipain RgpB Shows a Unique Zymogenic Mechanism for Cysteine Peptidases
【24h】

Porphyromonas gingivalis Virulence Factor Gingipain RgpB Shows a Unique Zymogenic Mechanism for Cysteine Peptidases

机译:Porphyromonas Gingivalis毒力因子Gingipain RGPB为半胱氨酸肽酶显示出独特的酶原机制

获取原文
           

摘要

Zymogenicity is a regulatory mechanism that prevents inadequate catalytic activity in the wrong context. It plays a central role in maintaining microbial virulence factors in an inactive form inside the pathogen until secretion. Among these virulence factors is the cysteine peptidase gingipain B (RgpB), which is the major virulence factor secreted by the periodontopathogen Porphyromonas gingivalis that attacks host vasculature and defense proteins. The structure of the complex between soluble mature RgpB, consisting of a catalytic domain and an immunoglobulin superfamily domain, and its 205-residue N-terminal prodomain, the largest structurally characterized to date for a cysteine peptidase, reveals a novel fold for the prodomain that is distantly related to sugar-binding lectins. It attaches laterally to the catalytic domain through a large concave surface. The main determinant for latency is a surface “inhibitory loop,” which approaches the active-site cleft of the enzyme on its non-primed side in a substrate-like manner. It inserts an arginine (Arg126) into the S1 pocket, thus matching the substrate specificity of the enzyme. Downstream of Arg126, the polypeptide leaves the cleft, thereby preventing cleavage. Moreover, the carbonyl group of Arg126 establishes a very strong hydrogen bond with the co-catalytic histidine, His440, pulling it away from the catalytic cysteine, Cys473, and toward Glu381, which probably plays a role in orienting the side chain of His440 during catalysis. The present results provide the structural determinants of zymogenic inhibition of RgpB by way of a novel inhibitory mechanism for peptidases in general and open the field for the design of novel inhibitory strategies in the treatment of human periodontal disease.
机译:酶原是一种调节机制,可防止在错误背景下的催化活性不足。它在将病原体内的非活性形式维持微生物毒力因子至分泌物中起着重要作用。在这些毒力因子中是半胱氨酸肽酶Gingipain B(RGPB),其是攻击宿主血管系统和防御蛋白质的牙周病症卟啉肽的主要毒力因子。可溶性成熟RGPB之间的络合物的结构,由催化结构域和免疫球蛋白超家族结构域,及其205-残基N-末端前兆,其最大于半胱氨酸肽酶的结构表征,揭示了前一种新的折叠与糖结合凝集素无关。它通过大凹面横向地附着于催化结构域。潜伏期的主要决定因素是表面“抑制环”,其以基板的方式在其非灌注侧的酶的有效位点裂缝接近。它将精氨酸(Arg126)插入S1口袋中,从而匹配酶的底物特异性。在Arg126的下游,多肽留下裂缝,从而防止切割。此外,Arg126的羰基与助催化组氨酸,HIS440建立了非常强烈的氢键,将其从催化半胱氨酸,Cys473和朝向Glu381中汲取,这可能在催化期间在HIS440的侧链上发挥作用。本结果通过新的肽酶的新抑制机制,提供了抗βB的抗催化抑制的结构决定因素,并开启了用于治疗人牙周病的新型抑制策略的领域。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号